Skip to main content
. 2024 Nov 6;22:516. doi: 10.1186/s12916-024-03712-5

Table 3.

Adverse events

10 mg/kg 15 mg/kg 15 vs 10 p value 20 mg/kg 20 vs 10 p value Control group
SAEs
 Number of children ever having an SAE 3 (9%) 3 (9%) 1.00 4 (11%) 1.00 2 (4%)
 Number of SAEs 3 3 4 2
SAE criteria
 Fatal 1 (33%) 1 (33%) 1 (25%) 0 (0%)
 Life-threatening 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Caused or prolonged hospitalisation 2 (67%) 2 (67%) 3 (75%) 2 (100%)
 Persistent or significant disability/incapacity 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Other important medical condition 0 (0%) 0 (0%) 0 (0%) 0 (0%)

No further grade 3/4 AEs were reported that were not SAEs. No SAEs were judged to be related to azithromycin, the dose of azithromycin, or lead to a change in azithromycin